Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia - Wikidata - awgldk - TriplyDB

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

http://www.wikidata.org/entity/Q33895690

about

Defining Clinical Excellence in Adult Infectious Disease Practice The Impact of Infectious Disease Specialist Consultation for Staphylococcus aureus Bloodstream Infections: A Systematic Review The Association Between Geographic Density of Infectious Disease Physicians and Limb Preservation in Patients With Diabetic Foot Ulcers Clinical management of Staphylococcus aureus bacteremia: a review.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia.Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia Predicting risk for death from MRSA bacteremia.Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes.Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.Current management of bloodstream infections.Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia.Infectious diseases consultations at an Australian tertiary hospital: a review of 11,511 inpatient consultations.Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia.A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand.The infectious diseases physician in the future of healthcare: not only about antibiotic prescribing.The value of specialist care-infectious disease specialist referrals-why and for whom? A retrospective cohort study in a French tertiary hospital.Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with Staphylococcus aureus bacteraemia in Thuringia (SUPPORT): a study protocol of a cluster-randomised crossover trial.Transplant center support for infectious diseases.Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study.Impact of Infectious Disease Consultation on Clinical Management and Outcome of Patients with Bloodstream Infection: a Retrospective Cohort Study.The Value That Infectious Diseases Physicians Bring to the Healthcare System.Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital.Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs.Do hospitals need oncological critical care units?Editorial commentary: telephone consultation for Staphylococcus aureus bacteremia: opening Pandora's box.Genomic evolution of Staphylococcus aureus isolates colonizing the nares and progressing to bacteremia.Methicillin-sensitive Staphylococcus aureus bacteremia in aged patients: the importance of formal infectious specialist consultation.A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated stud

P2860

Q26700043-37294FC6-6DDA-4425-B9FA-2F96FF0CA8C0 Q26751492-2DC587D8-F76A-43C3-93CD-0CD4AAD60C7D Q33629074-F558CB90-4501-489F-9C81-6B0CF179A127 Q34441035-4B99FDA2-A396-4AD8-9BA7-30545C4EA753 Q34478074-D37EFAAA-69D4-44F5-81A2-A12C051CC91A Q35077842-D96783EE-61B0-4A62-AF7C-A6F20943C382 Q35668314-EBCA1394-91E0-4E52-B12C-ACFB7B7EBEEE Q36018479-039DA6C7-F7A8-4819-976E-18E71CC2C0B3 Q36037687-5F27692E-D9B3-44E0-95A5-26EAB80365D9 Q36296767-FF8011EF-F473-4446-9AB2-30198A5F7FF8 Q37203845-8CF36F50-04B8-484A-B7EB-65B28FC77C4B Q37768418-2BB02614-092E-471B-A694-A21E4C5ADED7 Q38127663-A5E9407A-0191-4C49-B25D-2ED37C7922D9 Q38232749-A7C87238-2AD7-43BD-AE08-21973D51049C Q38747527-039B92B2-B478-404A-9668-45F169215209 Q38853319-4CDD444C-0425-423C-B6CB-23E04C0615B1 Q39013344-92F7AB1F-B82D-4F25-8CFD-603312AC4393 Q39095157-52A3269A-41D5-4217-B5BC-89EDE45F882C Q39178565-667316BA-A238-4471-819E-4D1AE22BB9EB Q39585387-7B4E8976-B938-4528-9ED1-2EE0F8A652FE Q40138678-4BB4442B-0BDB-45AD-B727-E5D23E441B31 Q41471926-C537D275-7995-4182-9233-E44DF687934F Q41987514-547FE5D6-FFD3-46D5-8EB3-1CBA82D7020B Q41995199-C6C3D22B-82D4-471B-8C4B-FAC1DCF79157 Q42212602-A1184FAC-1AB5-4348-94F2-A64DCBD83FBF Q42246315-7CB101D9-C13E-4A74-A28A-D341564DA400 Q42362328-68443C5A-CDF0-4B3B-A213-1409DCFB537D Q45149970-F698F924-2DB8-4C8D-8DFA-F4C00A09F3DE Q54993751-36107C49-2D65-42DD-98DB-59DC31028A0E Q55379607-2782722A-424B-4E2F-9F57-89C80B1F8EAC Q55496455-EC1043A9-177B-41F7-B1EC-E83CC385B210

P2860

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

http://www.wikidata.org/entity/Q33895690

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

@ast

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

@en

type

label

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

@ast

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

@en

prefLabel

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

@ast

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

@en

P1433

Q33895690-8DD1F962-23C2-4451-AACC-3704C276EB03

P1476

Q33895690-0A5F4ABE-816F-47E6-9686-638EEE6CEE1F

P2093

Q33895690-19619EE5-3E5A-4E09-B626-861071733553

Q33895690-58FF3B78-4AB4-499C-833C-6D340A9DA55F

Q33895690-8230AD53-FDEF-411E-8B4C-5EE9B5E2ADCB

Q33895690-9C8E8D1F-AD40-4650-AB0E-E7C672884983

Q33895690-B2DD4FBB-7BD9-4FFE-800A-52268C679430

P2860

Q33895690-2405466E-46F5-46D2-94BC-35AB75D04AC5

Q33895690-42413B9D-DBDC-49D9-875F-33C27A600BEE

Q33895690-5C380623-925F-4828-8DF5-2136E68B9D47

Q33895690-6BC31088-7966-4ED0-A42E-DAC78892D1CD

Q33895690-774815AE-5CD2-4D39-B75A-A723EBF25DE9

Q33895690-7BD3495D-55A0-4FFD-AC69-8C808A676324

Q33895690-7D8C34AD-3005-4239-948F-803EECFC3213

Q33895690-BAC29DA3-15FF-41FC-8229-11151997126B

Q33895690-BAD1E1FD-5339-4E8D-8D0B-D88EEFF06EDE

Q33895690-C1697B72-1ABD-41BB-99DA-B58D08618855

P304

Q33895690-A5D2BD14-BD74-4701-A1A1-F734C0E63BC4

P31

Q33895690-8BF120FF-49D8-4673-8751-9A21F1D2D838

P356

Q33895690-C37F7FA8-FE54-42D4-AE44-D13C88685E84

P407

Q33895690-56C201F4-EC19-48B6-ADA3-92E4B9963DE1

P433

Q33895690-2A3AF83E-C99B-40AE-899E-7C2FFD6D88D3

P478

Q33895690-5514E684-C254-4D3A-8E07-D50A870D2328

P577

Q33895690-30CE6C98-EB84-49AC-9B83-F783CCB02DD0

P698

Q33895690-F1789969-84A7-4AD2-91E7-8BD3214CFF5B

P932

Q33895690-EA4B38CD-5250-456F-8933-FEBDD8CBB638

P356

MD.0B013E3181B8FCCB

P1433

P1476

Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia

@en

P2093

Jennifer Gittzus

http://www.w3.org/2001/XMLSchema#string

Joseph Schwartzman

http://www.w3.org/2001/XMLSchema#string

Kathryn Kirkland

http://www.w3.org/2001/XMLSchema#string

Ruta Shah

http://www.w3.org/2001/XMLSchema#string

Timothy Lahey

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia.

Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey.

Management of methicillin-resistant Staphylococcus aureus bacteremia.

CDC definitions for nosocomial infections, 1988

A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.

Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility.

Strategic alliance between the infectious diseases specialist and intensive care unit physician for change in antibiotic use.

P304

263-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0B013E3181B8FCCB

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19745684

http://www.w3.org/2001/XMLSchema#string

P932

2881213

http://www.w3.org/2001/XMLSchema#string